Home Measurement of factor XIII activity in plasma
Article Publicly Available

Measurement of factor XIII activity in plasma

  • Éva Katona

    Éva Katona PhD is a senior research fellow at the Clinical Research Center of the Medical and Health Science Center, University of Debrecen. She became a certified clinical biochemist in 2006. Her main field of research is the development of new immunodiagnostic methods and reagents on the field of thrombosis and hemostasis. She is also involved in exploring the structure-function relationship of coagulation factors, especially factor XIII, and in studying the relationships between blood coagulation/fibrinolytic factors and vascular disorders. She has published 36 articles in scientific journals (total impact factor: 118). She has given lectures and practical courses for undergraduate and graduate students studying for a degree in clinical laboratory analytics and in clinical laboratory science for many years. She is involved in supervising PhD students and she is the secretary of a Doctoral School at the University.

    , Krisztina Pénzes

    Krisztina Pénzes-Daku has a BSc in Medical Laboratory Diagnostics and an MSc in Molecular Biology. She has completed 3 years of PhD studies and is about to defend her thesis. She is employed as an assistant lecturer at the Clinical Research Center, University of Debrecen, Medical and Health Science Center. Her main area of research is the interaction of activated coagulation factor XIII with substrates, development of new factor XIII substrates and inhibitors. She has published scientific papers and had presentations at international scientific congresses.

    , Éva Molnár

    Éva Molnár has a BSc in Medical Laboratory Diagnostics. She is employed as a laboratory analyst at the Clinical Research Center, University of Debrecen, Medical and Health Science Center. She has been working on the development of new laboratory methods in the field of thrombosis and hemostasis, among others and on new factor XIII assays, and is highly experienced in the quality control of hemostatic diagnostic tests. She had several presentations at scientific congresses.

    and László Muszbek

    Prof. László Muszbek MD, PhD is a Member of the Hungarian Academy of Sciences. He has been employed at the University of Debrecen, Medical and Health Science Center and has been Chairman of the Department of Clinical Biochemistry and Molecular Pathology (1978–2004) and Director of Clinical Research Center (2004–present). He has held Visiting Fellowships and Professorships at the National Institute of Health, Bethesda, MD, University of Pennsylvania, Department of Pathology, Philadelphia, PA, Massachusetts General Hospital, Harvard University, Department of Pathology, Boston, MA. His main research areas include thrombosis and hemostasis and laboratory diagnostics. He has published 233 scientific papers, with an impact factor of 530 and been cited over 3000 times. He is involved in many international organizations including the Forum of European Societies of Clinical Chemistry as a Board Member and Treasurer (1993–1996), the International Federation of Clinical Chemistry and Laboratory Medicine as an executive board member (1997–1999), the European Thrombosis Research Organization as the General Secretary (2000–2003) and President (2007–2010), the International Society on Thrombosis and Haemostasis as a member of the Scientific and Standardization Committee (1997–2003) and has been a member of Senior Advisory Council (2003–present). He is an Editorial Board member of Blood Coagulation and Fibrinolysis, an Associate Editor of Thrombosis Research and is an Associate Editor of Thrombosis and Haemostasis (2007–2011).

    EMAIL logo
Published/Copyright: February 23, 2012

Received: 2011-10-07
Accepted: 2012-01-23
Published Online: 2012-02-23
Published in Print: 2012-07-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
  5. Reviews
  6. European medical laboratory accreditation. Present situation and steps to harmonisation
  7. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
  8. Translating exome sequencing from research to clinical diagnostics
  9. Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
  10. Pregnancy-associated plasma protein A: spotlight on kidney diseases
  11. Measurement of factor XIII activity in plasma
  12. Update on multiple sclerosis, its diagnosis and treatments
  13. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
  14. Mini Reviews
  15. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
  16. Highlights in inflammatory bowel disease – from bench to bedside
  17. Opinion Papers
  18. Implementation of standardization in clinical practice: not always an easy task
  19. IFCC standardised HbA1c: should the world be as one?
  20. Reflective testing: adding value to laboratory testing
  21. Original Articles
  22. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  23. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
  24. Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
  25. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0730/html
Scroll to top button